SM

Sudhir Mahadev Dongare

Active Director Director DIN 09335627
DIN 09335627 First appointment Sep 2021 Primary industry Service
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Sudhir Mahadev Dongare

Data last updated:

Sudhir Mahadev Dongare is a Director at Atili Pharma Private Limited (since 2021). The company operates in Service.

DIN 09335627
Primary Designation Director
Industry Service
First Appointment 27 Sep 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Atili Pharma Private Limited U93090TG2021PTC155338
Director27 Sep 20212021Active

Board colleagues of Sudhir Mahadev Dongare

NameDINCompanyDesignation
Tejaswini Abhay Neb09335628Atili Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Atili Pharma Private Limited
Premium access

Shareholding and investment profile for Sudhir Mahadev Dongare

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sudhir Mahadev Dongare

Sudhir Mahadev Dongare currently holds 1 directorship: Atili Pharma Private Limited (Director, since 27 Sep 2021).

Sudhir Mahadev Dongare was first appointed on 27 Sep 2021 as Director at Atili Pharma Private Limited.

The current boards of Sudhir Mahadev Dongare's companies include Tejaswini Abhay Neb (Atili Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available